![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/18 | |
A61P 3/10 |
(11) | Number of the document | 3062881 |
(13) | Kind of document | T |
(96) | European patent application number | 14857066.6 |
Date of filing the European patent application | 2014-10-27 | |
(97) | Date of publication of the European application | 2016-09-07 |
(45) | Date of publication and mention of the grant of the patent | 2019-10-02 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/062378 |
Date | 2014-10-27 |
(87) | Number | WO 2015/065897 |
Date | 2015-05-07 |
(30) | Number | Date | Country code |
201361896473 P | 2013-10-28 | US | |
201361922586 P | 2013-12-31 | US | |
201462067273 P | 2014-10-22 | US |
(72) |
LING, Lei, US
|
(73) |
NGM Biopharmaceuticals, Inc.,
333 Oyster Point Blvd., South San Francisco CA 94080,
US
|
(54) | CANCER MODELS AND ASSOCIATED METHODS |
CANCER MODELS AND ASSOCIATED METHODS |